We have observed
4 EP applications
Caroline Chantal Patricia Pallard
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after June 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
GENE THERAPY COMPOSITION FOR USE IN DIABETES TREATMENT
SELECTIVE ELIMINATION OF EROSIVE CELLS
Humanized anti-human NKG2A monoclonal antibody
NOVEL METHOD FOR DIAGNOSING LYME DISEASE USING A CELLULAR IMMUNOLOGICAL TEST